Moreover, aminomethylenethiophenes (AMTs) is a potent oral bioavailable anti-tumor agent targeting dual LOX and LOXL2 and exhibit improved pharmacokinetic properties and excellent antitumor efficacy in vivo [570]. This evidence concerns the gene LOXL2 and neoplasm.